Nara, Japan

Kazuaki Kakehi




Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1992-2015

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: Kazuaki Kakehi: Innovator in Allergic Disease Treatment

Introduction

Kazuaki Kakehi is a prominent inventor based in Nara, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of allergic diseases. With a total of nine patents to his name, Kakehi's work has the potential to impact many lives.

Latest Patents

Kakehi's latest patents include a low-molecular polysulfated hyaluronic acid derivative, which is useful for treating allergic diseases. This innovative derivative is designed to address conditions such as pollinosis, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma. The patent outlines a general formula where 'n' represents a number from 0 to 15, and R's can independently represent a hydrogen atom or an SOH group. Another notable patent involves a process for producing a sugar chain derivative, which includes steps for introducing a lipophilic group into oligosaccharides and treating the resulting mixture through serotonin affinity column chromatography.

Career Highlights

Throughout his career, Kakehi has worked with notable companies, including Otsuka Chemical Co., Ltd. His expertise in the field has led to advancements in medical treatments and innovative processes.

Collaborations

Kakehi has collaborated with esteemed colleagues such as Yasuhiro Kajihara and Kazuhiro Fukae. These partnerships have contributed to the development of his groundbreaking patents and research.

Conclusion

Kazuaki Kakehi's contributions to the field of medicine, particularly in the treatment of allergic diseases, highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing medical science and providing solutions for those affected by allergies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…